• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Learn Why The Bull Case For Butterfly Network (BFLY) Could Change Following Focalist System Launch

    Simply Wall St·10/03/2026 06:23:24
    Listen to the news
    • Mendaera, Inc. announced that its Focalist system is now commercially available with Butterfly Network’s Ultrasound-on-Chip imaging and a customized Butterfly iQ3 probe, representing the first Butterfly Embedded partner technology to reach the market.
    • This launch gives Butterfly Network a concrete proof point for its Embedded program, showing that third parties can integrate its ultrasound technology into robotic intervention workflows and potentially widen real-world use cases beyond handheld devices.
    • We will now look at how this first Butterfly Embedded market launch could influence Butterfly Network's broader investment narrative.

    Scan how Butterfly Network fits into the broader shift toward AI-enabled healthcare robotics by comparing it with 35 healthcare AI stocks that are already pushing this theme across the market.

    Butterfly Network Investment Narrative Recap

    To own Butterfly Network, you need to believe handheld and embedded ultrasound can become a standard tool in more care settings, and that software and AI will matter as much as hardware. The Mendaera Focalist launch gives a concrete, but narrow, proof point for the embedded strategy. On its own, it does not change the biggest near term catalyst, which is still execution on large enterprise and medical school deployments.

    The central risk stays the same. Butterfly remains loss making, spends heavily on AI and chip development, and faces signs of uneven traction in its core market, with flat domestic trends and pressure on subscription renewals. If these issues persist, the Mendaera news may end up more validation story than financial swing factor.

    The clearest related catalyst is still Butterfly’s focus on AI driven software platforms like Compass AI and Butterfly Garden. The Mendaera partnership leans on the same idea that ultrasound value shifts toward software defined imaging and workflow, whether at the bedside, in education, or inside a robot guided procedure room.

    For you as an investor, the question is whether management can turn that software thesis into broader, stickier contracts that offset risks from volatile global projects, insider selling, and continued operating losses. Progress on AI apps, HomeCare pilots, and now Embedded partners gives more surface area for success, but also demands cleaner execution and funding discipline.

    Butterfly Network's current analyst story points to US$258.1 million in revenue and US$32.5 million in earnings by 2029, based on an assumed 32.0% yearly rise in revenue and an earnings swing of about US$107.3 million from a loss of US$74.8 million today.

    Uncover why Butterfly Network's fair value indicates a 27% potential upside to its current price that could narrow quickly.

    NYSE:BFLY 1-Year Stock Price Chart
    NYSE:BFLY 1-Year Stock Price Chart

    Exploring Other Perspectives

    One alternate take on Butterfly Network leans heavily on a single concern: shrinking high margin software revenue and persistent churn. The most cautious analysts were only modeling US$217.2 million of revenue and US$27.3 million of earnings by 2029, which supports a more muted view that this Mendaera news could eventually reshape.

    Explore 4 other Butterfly Network fair value estimates, including one that suggests as much as 80% downside from the current price!

    Reach Your Own Conclusion

    Don't just follow the ticker; dig into the data and build a conviction that's truly your own.

    Looking for more Butterfly Network style investment ideas?

    If the Butterfly Network story has you thinking about where else emerging themes could play out, it can help to scan a wider field of opportunities using structured screeners rather than relying on headlines alone.

    • For investors who want potential upside with strict financial filters on size and quality, consider starting with a focused group of 9 elite penny stocks with strong financials that meet those criteria.
    • If the goal is to balance quality with price and look beyond the most widely followed tickers, filter for companies in the 19 high quality undiscovered gems that pair solid fundamentals with less crowd attention.
    • For a more defensive angle that aims to keep downside risk in check, review a curated 31 resilient stocks with low risk scores that screens for resilient balance sheets and lower volatility profiles.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.